Vanguard Capital Management’s Immix Biopharma IMMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.2M Buy
3,002,000
+494,878
+20% +$5.6M ﹤0.01% 2157
2026
Q2
$25.8M Buy
2,507,122
+719,128
+40% +$6.67M ﹤0.01% 2306
2026
Q1
$16.3M Buy
+1,787,994
New +$13.1M ﹤0.01% 2456

Other funds holding IMMX

Vanguard Capital Management's IMMX Position: Q3 2026 in Review

Vanguard Capital Management increased its Immix Biopharma (IMMX) stake by 20% in Q3 2026, buying an estimated $5.6M and bringing the position to 3,002,000 shares worth $31.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2157.

Vanguard Capital Management first reported a position in IMMX in Q1 2026 and has held it in 3 quarters since. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Vanguard Capital Management held 3,002,000 shares of Immix Biopharma worth $31.2M as of Q3 2026.
  • Vanguard Capital Management bought 494,878 Immix Biopharma shares in Q3 2026, an estimated $5.6M.
  • Immix Biopharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2157 holding.
  • Vanguard Capital Management first reported a position in Immix Biopharma in Q1 2026 and has held it in 3 quarters since.
  • 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.